Interesting: New landmark collaboration between the Serum Institute of India (SII), Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation to accelerate manufacturing and delivery of up to 100 million doses of future safe and effective COVID-19 vaccines for low- and middle-income countries in 2021 Vaccines will be priced at maximum US$ 3 per dose and made available to up to 92 countries included in Gavi’s COVAX Advance Market Commitment (AMC) Dr Seth Berkley: New collaboration will help “ensure we have additional manufacturing capacity to begin producing doses for every country, not just the wealthy few”